drugset / Trial / NCT03158116

The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas

NCT03158116

NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, case-control clinical trial using inhaled Aztreonam (AZLI) in pediatric patients with a tracheostomy tube colonized with Pseudomonas aeruginosa. The aim of the study is to see if AZLI being taken in a one month on / one month off cycle over the course of a year can decrease the need for systemic antibiotics and/or hospitalizations.

Timeline

Start
2017-07-01
Primary completion
2020-02-20
Completion
2020-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Aztreonam Small molecule Inhaled

Indications